This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This GNL1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 240-266 amino acids from the Central region of human GNL1.
GNL1
Reaktivität: Human
ELISA
Wirt: Kaninchen
Polyclonal
HRP
Applikationshinweise
For WB starting dilution is: 1:1000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.42 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
GNL1
(Guanine Nucleotide Binding Protein Like Protein 1 (GNL1))
HSR1 antikoerper, Gna-rs1 antikoerper, Gnal1 antikoerper, G protein nucleolar 1 (putative) antikoerper, guanine nucleotide binding protein-like 1 antikoerper, G protein nucleolar 1 antikoerper, GNL1 antikoerper, Gnl1 antikoerper
Hintergrund
The GNL1 gene, identified in the human major histocompatibility complex class I region, shows a high degree of similarity with its mouse counterpart. The GNL1 gene is located less than 2 kb centromeric to HLA-E, in the same transcriptional orientation. GNL1 is telomeric to HLA-B and HLA-C. [provided by RefSeq].